3543 results for «2133»
3543 results
New 2021 ESC heart failure and valvular heart diseases guidelines : impact on secondary mitral regurgitation management
21 Nov 2021 – From PCR London Valves 2021
Join Ralph Stephan Von Bardeleben and Marco Metra if you want to learn about the new ESC 2021 guidelines in heart failure management and the key interconnections between the heart failure and the valvular heart diseases guidelines, as well as to understand how this will improve...
TAVI valve and implantation technique: the secrets for optimising outcomes
21 Nov 2021 – From PCR London Valves 2021
Join Neil Moat, Helge Möllmann, Lars Søndergaard and Ganesh Manoharan to hear the experience of an account achieve single digit permanent pacemaker implantation, to learn how to preserve coronary access for future patients' treatment, and to see how new product features can reduce paravalvular leak.
Closing TAVI with next generation suture mediated closure device
21 Nov 2021 – From PCR London Valves 2021
Join Francesco Maisano to learn more about about the Perclose ProStyle, a next generation closure device for TAVI procedures, and discover some interesting tips & tricks.
The science behind a valve designed for life
21 Nov 2021 – From PCR London Valves 2021
Join Christopher Meduri if you want to understand the features of a transcatheter heart valve that is designed to last the life of the patient, why a 3D single-piece aortic valve design can provide near normal pre-disease hemodynamics and how tissue science impacts leaflet preservation and...
PCR London Valves 2021 Hotlines / Late-Breaking Trials: bRIGHT, EXPAND, CHOICE-MI
21 Nov 2021 – From PCR London Valves
Real-world outcomes for tricuspid edge-to-edge repair, predictors of heart failure hospitalisation and its impact on clinical outcomes, one-year outcomes after TMVI... View part of the Late-Breaking Trials presented during PCR London Valves 2021.
A heart-team discussion for tricuspid valve intervention
21 Nov 2021 – From PCR London Valves 2021
Join Vinayak Bapat, Joao Cavalcante and Paul Sorajja to learn about how the heart-team approaches tricuspid valve intervention, how to pre-procedurally plan transcatheter tricuspid valve repair/replacement and how to intra-operatively guide TTVR using imaging.
Patient-specific implantation technique to obtain neo-commissural alignment with self-expanding transcatheter aortic valves (COMALIGN)
21 Nov 2021 – From PCR London Valves 2021
Join Lars Søndergaard and Ole De Backer if you want to learn about why patient-specific implantation techniques are important to obtain commissural alignment, which imaging techniques are needed to achieve commissural alignment, as well as how valve and delivery system designs impact outcomes and success rates.
Periprocedural outcomes of MANTA vascular closure device used in large-bore arterial access following VARC-3 definitions. More scientific evidence behind plug-based vascular closure device
21 Nov 2021 – From PCR London Valves 2021
Join Simon Redwood, Radoslaw Parma and Nicolas Van Mieghem if you want to learn about the results of the latest 120 patient MANTA registry, the best practices comparing to similar registries of the past, as well as tips and tricks on how to use MANTA vascular...
Intravascular lithotripsy: expanding the boundaries of transfemoral TAVI
21 Nov 2021 – From PCR London Valves 2021
Join Sam Dawkins, Ole De Backer and Carlo Di Mario to learn about the latest news regarding intravascular lithotripsy and how it may impact the future of transfemoral TAVI.
SURTAVI five-year outcomes - What do you need to know considering the new ESC guidelines?
21 Nov 2021 – From PCR London Valves 2021
Join Nicolas Van Mieghem, Nicole Karam and Thomas Modine to learn more about about SURTAVI five-year study outcomes and to discover which factors are impacting valve performance overtime.
Cusp overlap technique - How it evolved my practice?
21 Nov 2021 – From PCR London Valves 2021
Join Darren Mylotte, Derk Frank and Vincent Roolvink if you want to discover real-life practices with the Cusp Overlap technique, as well as to learn about its adoption benefits and its essentials procedural steps.
Predictability at release means better MR outcomes; PASCAL platform significance in a matched analysis
21 Nov 2021 – From PCR London Valves 2021
Join Peter Lüdike and Philipp Lurz to learn more about about the latest study regarding the predictability of mitral regurgitation reduction using the PASCAL device.
Lean TAVI: safe efficiencies and better economics
21 Nov 2021 – From PCR London Valves 2021
Join Dider Tchétché and Stefan Toggweiler if you want to learn about the Lean TAVI practice and the Lucerne study results, the Lean TAVI adoption at other centres / Heart Teams, as well as the procedural efficiencies and their importance in the success of the overall...
The uncompromised hemodynamics of the ALLEGRA transfemoral TAVI system in clinical practice
21 Nov 2021 – From PCR London Valves 2021
Join Raúl Moreno, Julian Widder and Mathias Wolfrum if you want to learn about a single-centre experience of their first 100 patients treated with the ALLEGRA, and to see clinical outcome data on over 250 cases treated with ALLEGRA from a European multicentre registry.
EAPCI: patient initiatives around the world
22 Nov 2021 – From PCR London Valves 2021
In this session, you can find out more about the EAPCI Valve for Life initiative and what progress has been made in selected countries, as well as other collaborative initiatives across the world.
Mitra-leaks
21 Nov 2021 – From PCR London Valves 2021
Visualize a complex mitral paravalvular leak, a complex paravalvular leak closure, or a percutaneous closure of a severe paravalvular leak post TMVR-in-MAC in one sole session from the PCR London Valves 2021!
Right-side THV implantation
21 Nov 2021 – From PCR London Valves 2021
Watch this PCR London Valves 2021 session to learn more about tricuspid valve-in-ring for severe symptomatic tricuspid regurgitation, to consider the transcatheter heart valve for isolated tricuspid regurgitation, and to see an unresolved complication in transcatheter tricuspid ViV, among others.
Aortic valve disease: treatment and patient selection
21 Nov 2021 – From PCR London Valves 2021
Let's talk about severe asymptomatic aortic stenosis: what are the surgical standpoint and recent data from surgical literature? How to assess these patients? How to analyze CT? What do the newly published VHD Guidelines say? What is the place of MRI in these patients? So many questions...
Understanding the anatomy of the tricuspid valve: similarities with and differences from the mitral valve
21 Nov 2021 – From PCR London Valves 2021
With this session on the tricuspid valve, learn to understand the anatomical features relevant to the procedures, become more familiar with different imaging modalities, and get hands-on by examining interactions between leaflets and some devices.
Lifetime management of TAVI patient
15 Dec 2021 – From GulfPCR-GIM 2021
In this session, start viewing the case of a 67-year-old female patient with hypertension and severe symptomatic aortic stenosis used to illustrate TAVI in very small aortic annulus, and, then, follow the discussion about smallest annulus treated with TAVI and lifetime management of TAVI patient.
